U.S. Stock News

NasdaqGS:LOPE
NasdaqGS:LOPEConsumer Services

What Grand Canyon Education (LOPE)'s Higher EPS, Raised 2026 Guidance and Buybacks Mean For Shareholders

In the past quarter, Grand Canyon Education, Inc. reported higher net income of US$45.85 million and diluted EPS of US$1.75 for the second quarter and raised its full‑year 2026 earnings guidance, while also confirming it has repurchased 22,616,124 shares under its long-running buyback program. An interesting angle for investors is how management’s latest guidance for full‑year diluted EPS of US$9.93–US$10.07 now frames expectations against the company’s long-term service revenue model and...
NYSE:HIMS
NYSE:HIMSHealthcare

Hims & Hers (HIMS) Stock Rally Meets Margin Pressure And GAAP Loss

The story with Hims & Hers Health today is the gap between the selloff and the scoreboard. The stock slipped about 4% to US$30.55 after earnings, even though Q2 revenue landed at US$753m and adjusted earnings before interest, tax, depreciation and amortization reached US$60m. That tension between a red screen and a growing telehealth platform is what matters for you as an investor. Heading into the print, Hims & Hers Health had rallied sharply over the past three months, then cooled over the...
NasdaqCM:FRHC
NasdaqCM:FRHCCapital Markets

Freedom Holding (FRHC) Stock Trades At A Premium Following Its 139% Five Year Run

Freedom Holding stock has more than doubled over the past five years, yet the current valuation checks suggest the shares may not offer obvious value at today’s price. With the company expanding its banking and digital ecosystem in markets such as Turkiye, investors are weighing that growth story against signals that the stock leans expensive. Freedom Holding has returned about 139.1% over the past five years, which puts recent price weakness into context as a longer term gain that investors...
NYSE:FERG
NYSE:FERGTrade Distributors

Ferguson (FERG) Stock Pullback Follows Solid Growth And Premium P/E

Ferguson Enterprises stock was riding a solid 30 day gain coming into this earnings print. The shares then dropped about 4.7% today. That is a sharp reset for a distributor that many investors view as a steady compounder in plumbing, HVAC and infrastructure. The headline is simple: earnings held up better than the price reaction suggests. Revenue reached about US$8.8b in the quarter and diluted earnings per share came in around US$3.39. Trailing 12 month earnings of just over US$10 per share...
NYSE:KMI
NYSE:KMIOil and Gas

The Bull Case For Kinder Morgan (KMI) Could Change Following Western Gateway Pipeline Joint Venture - Learn Why

Kinder Morgan recently joined Phillips 66 and HF Sinclair in announcing a joint venture to develop the Western Gateway Pipeline system, expanding its role in transporting energy products across key North American corridors. This collaboration highlights how Kinder Morgan can use its extensive infrastructure and strong free cash flow to pursue capital projects alongside industry peers. We’ll now examine how Kinder Morgan’s Western Gateway Pipeline joint venture could influence its investment...
NYSE:UNH
NYSE:UNHHealthcare

UnitedHealth (UNH) Stock Slips As Medical Cost Fears Mute Profit Rebound

UnitedHealth Group just delivered a punchy earnings headline while the stock quietly slipped. Shares closed at US$402.20, down about 1.6% on the day and modestly weaker over the past month, even as quarterly adjusted earnings per share landed at US$6.38 and operating earnings rose sharply compared with a year ago. The market looks more cautious than the numbers alone might suggest. Investors seem to be discounting the earnings strength and raised full year guidance, and instead leaning into...
NasdaqGS:FIP
NasdaqGS:FIPTransportation

FTAI Infrastructure (FIP) Record EBITDA Clashes With Deepening Losses

FTAI Infrastructure entered this earnings season with a troubled reputation and low expectations, yet the stock nudged 1.6% higher to about US$4.37 by the close. The market is trying to price in a potential turnaround story while the income statement still shows heavy red ink. Q2 revenue came in at about US$186.8 million, but the company reported a net loss of roughly US$166.5 million and basic earnings per share of a loss of US$1.41. The real headline is not the modest price increase...
NYSE:GDOT
NYSE:GDOTConsumer Finance

Green Dot (GDOT) Stock Shrugs Off Profit Surge As Loss Questions Linger

Green Dot stock barely flinched after earnings, ticking up about 1% to US$13.41, yet the numbers point to a far more dramatic story than the share price suggests. A consumer finance company that has been wrestling with rising losses just put up one of its cleanest quarterly profit lines in recent memory, with Q1 2026 basic earnings per share at US$0.96 on revenue of US$654.7m. For a business that has reported trailing twelve month net income losses, this kind of earnings power instantly...
NYSEAM:CMCL
NYSEAM:CMCLMetals and Mining

Caledonia Mining (NYSEAM:CMCL) Stock Eyes Bilboes As Earnings Stay Strong

Caledonia Mining stock closed up 1.1% at US$22.97, a calm move for what is a punchy set of numbers. The market treated today as a small win. The income statement looks more like a statement of intent. The headline is earnings power. Second quarter basic earnings per share landed at US$1.36 on revenue of about US$72.0m, with net income of US$23.8m. That keeps the trailing twelve month profit picture firm and leaves Caledonia Mining trading on a single digit P/E multiple. Short term traders saw...
NasdaqCM:DRTS
NasdaqCM:DRTSMedical Equipment

Alpha Tau Medical (DRTS) Clinical Progress Tests Whether The Stock Already Looks Fully Valued

Alpha Tau Medical earnings put recent clinical progress in context Alpha Tau Medical (NasdaqCM:DRTS) has paired a series of high profile clinical and partnership milestones with fresh half year results that show a wider net loss and higher loss per share. The company reported a net loss of US$68.75 million for the half year to June 30, 2026, compared with a loss of US$18.81 million a year earlier. Basic and diluted loss per share from continuing operations were both US$0.76, compared with...
NYSE:NE
NYSE:NEEnergy Services

Finding Value In Energy Stocks Trading Below Fair Value

Central banks are talking tougher on inflation, growth forecasts are being cut, and energy markets remain volatile, which puts the spotlight squarely on large energy stocks exposed to these pressures. For investors, this mix of risk and potential resilience can reshape how you think about where to put new money or what to hold. This article breaks down 3 energy stocks affected by the recent news and explains why each may warrant a closer look now. The three stocks covered below are just a...
NYSE:BIO
NYSE:BIOLife Sciences

Bio Rad Laboratories (BIO) Issues Flat Revenue Guidance, Is It Too Far Above Fair Value?

Bio-Rad Laboratories (BIO) has moved into focus after its second quarter 2026 earnings and fresh guidance, which combined a slight overall revenue decline with firmer contributions from several international markets. See our latest analysis for Bio-Rad Laboratories. The recent guidance and international revenue patterns arrived alongside a sharp shift in sentiment around Bio-Rad Laboratories, with a 46.30% 90 day share price return and a 29.66% 1 year total shareholder return contrasting with...
NYSE:TKR
NYSE:TKRMachinery

Should Timken’s Mixed Q2, Higher 2026 Outlook and Leadership Shake-Up Require Action From Timken (TKR) Investors?

In early August 2026, The Timken Company reported second-quarter results showing sales rising to US$1,260.9 million from US$1,173.4 million a year earlier, while net income fell to US$28.9 million from US$78.5 million, alongside confirming a US$0.36 quarterly dividend and completing a US$47.97 million share repurchase program. At the same time, Timken raised its 2026 earnings and revenue outlook and reworked its senior leadership team to support its Elevate to Outperform plan, signaling a...
NasdaqGS:ICHR
NasdaqGS:ICHRSemiconductor

Why Ichor Holdings (ICHR) Is Down 5.3% After Returning To Quarterly Profit And Raising Guidance – And What's Next

Ichor Holdings, Ltd. reported second-quarter 2026 results showing sales of US$294.78 million and net income of US$0.998 million, a shift from a loss a year earlier, and issued third-quarter revenue guidance of US$315 million to US$345 million with expected GAAP diluted EPS between US$0.25 and US$0.35. These results indicate improved profitability and higher sales compared with the prior year period, while the company’s forward guidance offers investors clearer expectations around revenue and...
NasdaqGS:APMD
NasdaqGS:APMDPharmaceuticals

Apnimed (APMD) Joins A Major Stock Index After IPO And Shelf Filing

Apnimed, Inc (NasdaqGS:APMD) has been added to the NASDAQ Composite Index following its recent IPO. The addition comes soon after Apnimed filed a shelf registration statement, signaling further corporate funding flexibility. Index inclusion typically draws attention from index-tracking funds and can affect trading volumes and liquidity. This kind of index move, combined with fresh IPO activity, points to a wider group of stocks that may be worth a closer look through 51 high quality...
NasdaqGS:FOXA
NasdaqGS:FOXAMedia

Fox Stock And 2 Sports Media Plays Tied To World Cup Rights Uncertainty

FIFA’s leadership turmoil and talk of boycotts has put the business of global football under an uncomfortable spotlight, from billion dollar media rights to sponsorships tied to future World Cups. That disruption risk also creates an opening for investors watching sports media and broadcasting stocks exposed to this news. This article breaks down how three stocks from our screener are positioned, so you can judge whether the story fits your portfolio. The stocks covered below are just a...
NasdaqGM:KEEL
NasdaqGM:KEELSoftware

Keel Infrastructure (KEEL) Stock Looks Cheap At First Glance Only

Keel Infrastructure stock has delivered a very strong 176.4% return over the past year, yet the company only passes 1 of 6 valuation checks, which raises questions about how much of that performance is supported by fundamentals after recent setbacks. The 176.4% one year gain stands in sharp contrast to the recent pullback. This may signal that expectations built up faster than the market is now comfortable with. The shift away from U.S. Bitcoin mining toward AI and high performance computing...
NasdaqGS:IMKT.A
NasdaqGS:IMKT.AConsumer Retailing

Does Ingles Markets' (IMKT.A) Earnings Resilience Outweigh Governance Questions After a Board Resignation?

Ingles Markets, Incorporated reported past third-quarter 2026 results with sales of US$1,368.32 million and net income of US$25.9 million, alongside higher nine‑month sales of US$4,049.16 million and net income of US$78.3 million versus the prior year. While quarterly earnings per share were almost unchanged, the nine‑month EPS from continuing operations rose to US$4.12, highlighting stronger year‑to‑date profitability despite a board resignation for personal reasons. We’ll now examine how...
NYSE:PEN
NYSE:PENMedical Equipment

Should Penumbra’s RED 68 Catheter Recall and Margin Strain Require Action From Penumbra (PEN) Investors?

Penumbra, Inc. recently initiated a voluntary Class II recall of its Penumbra System RED 68 Reperfusion Catheter across multiple US states and international markets due to manufacturing issues that may cause catheter fractures, following firm notifications sent out in early June 2026. This recall comes shortly after Penumbra reported higher quarterly sales of US$390.05 million but lower net income of US$34.81 million and reduced earnings per share versus a year earlier, highlighting growing...
NasdaqGM:SION
NasdaqGM:SIONBiotechs

Why Sionna Therapeutics (SION) Is Down 90.9% After Ending SION-719 Add-On To Trikafta Therapy

Sionna Therapeutics recently reported that its Phase 2a PreciSION CF trial of NBD1 stabilizer SION-719 added to Trikafta did not improve sweat chloride levels, leading the company to discontinue SION-719 as an add-on therapy and to reassess its clinical plans. At the same time, early data from SION-451 combination studies and a cash balance of about US$268.3 million give Sionna room to reconsider how it pursues cystic fibrosis therapies while preserving capital. We’ll now examine how...
NasdaqGS:CLBT
NasdaqGS:CLBTSoftware

3 AI And Data Analytics Stocks Worth Watching Right Now

As AI moves from buzzword to core toolkit for tracking inflation, jobs and growth in real time, investors are no longer limited to slow, revision prone government reports. That shift is creating a data gap between companies that power these new insights and everyone else, and missing it could mean missing the next big story. This article walks through three AI and data analytics stocks exposed to that news and explains why they stand out right now. The three stocks highlighted below are just...
NYSE:NPO
NYSE:NPOMachinery

Will Strong Q2 Results and Higher 2026 Guidance Change Enpro's (NPO) Advanced-Tech Narrative?

Enpro Inc. reported its second-quarter 2026 results, with sales rising to US$338.8 million and net income reaching US$27.1 million, while also affirming a quarterly dividend of US$0.32 per share payable in September 2026. The company also raised its 2026 revenue growth outlook to a range of 14% to 16%, indicating increased confidence relative to its prior expectations. Now we’ll assess how Enpro’s higher 2026 revenue growth guidance may reshape the existing investment narrative built on...
NYSE:MMM
NYSE:MMMIndustrials

Should Explosion-Related Safety Verdicts And Litigation Exposure Require Action From 3M (MMM) Investors?

A Harris County jury recently ordered 3M to pay US$61.5 million to Houston homeowners for its role in the 2020 Watson Grinding & Manufacturing explosion, after finding failures in servicing the facility’s gas detection and alarm systems contributed to the disaster. This third successful bellwether trial in the multi-district litigation highlights how 3M’s service practices for safety systems can translate into substantial legal liabilities and community impact. We’ll now examine how this...
NYSE:FNF
NYSE:FNFInsurance

Higher Bond Yields Are Putting These U.S. Insurance Stocks In Focus

With U.S. bond yields at multi year highs, inflation still above the Fed’s target, and markets second guessing what comes next under Kevin Warsh, interest rate sensitivity is firmly back in focus. That mix creates both risk and potential opportunity for investors watching how insurance stocks react to higher real yields. This article explains how the news relates to insurers and highlights 3 stocks from the screener to watch closely. The three insurers covered next are just a sample from this...